151 related articles for article (PubMed ID: 19446844)
1. Detection of multiple superantigen genes in stools of patients with Kawasaki disease.
Suenaga T; Suzuki H; Shibuta S; Takeuchi T; Yoshikawa N
J Pediatr; 2009 Aug; 155(2):266-70. PubMed ID: 19446844
[TBL] [Abstract][Full Text] [Related]
2. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
3. Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease.
Masuda K; Takei S; Nomura Y; Imanaka H; Sameshima K; Yoshinaga M
Pediatr Res; 1998 Jul; 44(1):27-31. PubMed ID: 9667366
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
Gupta-Malhotra M; Viteri-Jackson A; Thomas W; Zabriskie JB
Exp Mol Pathol; 2004 Apr; 76(2):117-21. PubMed ID: 15010289
[TBL] [Abstract][Full Text] [Related]
5. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.
Nomura Y; Yoshinaga M; Masuda K; Takei S; Miyata K
J Infect Dis; 2002 Jun; 185(11):1677-80. PubMed ID: 12023778
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.
Leung DY; Meissner HC; Shulman ST; Mason WH; Gerber MA; Glode MP; Myones BL; Wheeler JG; Ruthazer R; Schlievert PM
J Pediatr; 2002 Jun; 140(6):742-6. PubMed ID: 12072880
[TBL] [Abstract][Full Text] [Related]
7. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease.
Yoshioka T; Matsutani T; Toyosaki-Maeda T; Suzuki H; Uemura S; Suzuki R; Koike M; Hinuma Y
Pediatr Res; 2003 Mar; 53(3):403-10. PubMed ID: 12595587
[TBL] [Abstract][Full Text] [Related]
8. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age.
Nomura Y; Masuda K; Yoshinaga M; Takei S; Miyata K
Pediatr Infect Dis J; 2003 Sep; 22(9):794-8. PubMed ID: 14506370
[TBL] [Abstract][Full Text] [Related]
9. Detection of streptococcal pyrogenic exotoxin genes by a nested polymerase chain reaction.
Black CM; Talkington DF; Messmer TO; Facklam RR; Hornes E; Olsvik O
Mol Cell Probes; 1993 Aug; 7(4):255-9. PubMed ID: 8232341
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of Kawasaki disease and superantigens.
Uchiyama T; Kato H
Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
[TBL] [Abstract][Full Text] [Related]
11. A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity.
Lintges M; Arlt S; Uciechowski P; Plümäkers B; Reinert RR; Al-Lahham A; Lütticken R; Rink L
Int J Med Microbiol; 2007 Oct; 297(6):471-8. PubMed ID: 17481952
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus express unique superantigens depending on the tissue source.
Banks MC; Kamel NS; Zabriskie JB; Larone DH; Ursea D; Posnett DN
J Infect Dis; 2003 Jan; 187(1):77-86. PubMed ID: 12508149
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology.
Betley MJ; Borst DW; Regassa LB
Chem Immunol; 1992; 55():1-35. PubMed ID: 1418613
[No Abstract] [Full Text] [Related]
14. Survey of genes encoding staphylococcal enterotoxins, toxic shock syndrome toxin 1, and exfoliative toxins in members of the Staphylococcus sciuri group.
Dakić I; Vukovic D; Stepanović S; Hauschild T; Jezek P; Petrás P; Morrison D
J Clin Microbiol; 2005 Sep; 43(9):4875-6. PubMed ID: 16145164
[TBL] [Abstract][Full Text] [Related]
15. Superantigens SPEA and SMEZ do not affect secretome expression in Streptococcus pyogenes.
Russell HH; Sriskandan S
Microb Pathog; 2008 Jun; 44(6):537-43. PubMed ID: 18329243
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of staphylococcal superantigens.
Schlievert PM; Case LC
Methods Mol Biol; 2007; 391():113-26. PubMed ID: 18025673
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating superantigens in an intensive care unit population.
Azuma K; Koike K; Kobayashi T; Mochizuki T; Mashiko K; Yamamoto Y
Int J Infect Dis; 2004 Sep; 8(5):292-8. PubMed ID: 15325598
[TBL] [Abstract][Full Text] [Related]
18. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
Leung DY; Meissner C; Fulton D; Schlievert PM
J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
Brouillard JN; Günther S; Varma AK; Gryski I; Herfst CA; Rahman AK; Leung DY; Schlievert PM; Madrenas J; Sundberg EJ; McCormick JK
J Mol Biol; 2007 Apr; 367(4):925-34. PubMed ID: 17303163
[TBL] [Abstract][Full Text] [Related]
20. The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens.
Nur-ur Rahman AK; Bonsor DA; Herfst CA; Pollard F; Peirce M; Wyatt AW; Kasper KJ; Madrenas J; Sundberg EJ; McCormick JK
J Biol Chem; 2011 Feb; 286(6):4871-81. PubMed ID: 21127057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
